The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients

July 18, 2008 updated by: Meiji University of Oriental Medicine
Dry eye disease is related with oxidative stress at the ocular surface. GSH is one of the key factor of protect from oxidative stress. To evaluate thiol status of ocular surface cells by monitoring GSH concentration, we can evaluate the severity of dry eye.

Study Overview

Status

Unknown

Conditions

Detailed Description

The conjunctival cells are collected by impression cytology. Those cells are stained with 100 mM of monochlorobimane (MCB, M-1381, Molecular Probes, Eugene, OR) and propidium iodide (PI). Fluorescent intensity, reflecting the amount of icGSH, was inspected under a confocal laser scan microscope. To detect the GSH levels we used a fluorescent MCB probe with excitation and emission wavelengths of 405 nm and 410-480 nm, respectively. The cell-permeating MCB probe is non-fluorescent but forms a fluorescent adduct with GSH in a reaction catalyzed by glutathione-S-transferase.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Kyoto, Japan
        • Kyoto Prefectural University of Medicine hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The dry eye patients at the clinic of Kyoto Prefectural University of Medicine hospital

Description

Inclusion Criteria:

  • dry eye patients
  • control volunteers

Exclusion Criteria:

  • Young (less than 20) patients
  • The patients who rejected this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control

Cohorts and Interventions

Group / Cohort
Sjogren
Sjogren syndrome with dry eye
non-Sjogren
dry eye without Sjogren syndrome
Short-BUT
Dry eye by shortened tear break up time
control
normal patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Tear amount, tear break up time, and so on are measured clinically. The thiol redox status is measured by staining the membrane.
Time Frame: Once a month (totally 2-4 times) at the clinic
Once a month (totally 2-4 times) at the clinic

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Anticipated)

December 1, 2008

Study Completion (Anticipated)

March 1, 2010

Study Registration Dates

First Submitted

July 18, 2008

First Submitted That Met QC Criteria

July 18, 2008

First Posted (Estimate)

July 21, 2008

Study Record Updates

Last Update Posted (Estimate)

July 21, 2008

Last Update Submitted That Met QC Criteria

July 18, 2008

Last Verified

May 1, 2008

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dry Eye Disease

3
Subscribe